PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Apr-2024 Sports Nutrition Market to Witness Steady Expansion, Estimated at USD 86.0 Billion by 2032: Market.us Analysis Wired Release
02-Apr-2024 Women’s Health Rehabilitation Products Market Expected to Boom, Forecasted to Reach USD 7.7 Billion by 2032 Wired Release
02-Apr-2024 Vitamin D Testing Market Expected to Double by 2032, Growing at 7.9% CAGR: Latest Analysis Wired Release
02-Apr-2024 Growth Projection: Global Acute Ischemic Stroke Therapeutics Market to Exceed USD 14.0 Billion by 2032, Reports Market.us Wired Release
02-Apr-2024 Cisiv bolsters leadership team with appointment of Chief Delivery Officer Cisiv
02-Apr-2024 Cantargia Publishes Data Highlighting the Potential of CAN10 in Atherosclerosis AccessWire
02-Apr-2024 Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs Newswire
02-Apr-2024 Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs AccessWire
02-Apr-2024 Abivax reports 2023 financial results and operational update ABIVAX
02-Apr-2024 Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Avance Clinical
02-Apr-2024 CARTHERICS ENTERS INTO COLLABORATIVE RESEARCH AGREEMENT WITH TICAROS Cartherics
02-Apr-2024 Lonza Appoints Wolfgang Wienand as New Chief Executive Officer Lonza Group AG
02-Apr-2024 MedMira Reports Second Quarter Results FY2024 AccessWire
02-Apr-2024 FSD Pharma Announces Filing of Year-End 2023 Results AccessWire
01-Apr-2024 Spok(R) Clinches 7th Consecutive Title for Leading Satisfaction in Clinical Communications & Messaging, 2024 Black Book Annual Customer Experience Survey AccessWire
01-Apr-2024 Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024 AccessWire
01-Apr-2024 CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements AccessWire
01-Apr-2024 Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results AccessWire
01-Apr-2024 Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity AccessWire
01-Apr-2024 Ottobock North America Champions Freedom of Movement Through Limb Loss & Limb Difference Awareness Month Initiatives AccessWire